Press Releases :: Ligand Pharmaceuticals Incorporated (LGND)

Press Releases

Ligand Enters into OmniAb® Platform License Agreement with Pandion Therapeutics

January 13, 2020

Ligand to Report 2019 Fourth Quarter and Full Year Financial Results on February 6th

January 9, 2020

Two Ligand Pharmaceuticals Board Members Recognized as 2019 Most Influential Corporate Directors by WomenInc. Magazine

December 23, 2019

Ligand Enters into Worldwide OmniAb® Platform License Agreement with Sanofi

December 2, 2019

Ligand Pharmaceuticals Ranked in Deloitte’s 2019 Technology Fast 500™

November 12, 2019

Ligand Presents Positive Results from Phase 1 Clinical Trial of Captisol-enabled Iohexol

November 8, 2019

Ligand to Participate in the Stephens 2019 Nashville Investment Conference

November 7, 2019

Ligand Reports Third Quarter 2019 Financial Results

November 5, 2019

Ligand to Report Third Quarter 2019 Results on November 5th

October 22, 2019

Ligand Appoints Pharmaceutical Executive Sarah Boyce to its Board of Directors

October 15, 2019

1
2
3
4
5
6
7
8
9
10
...40
Next »